Bronchopulmonary dysplasia - A retrospective analysis of different forms of treatments and design of a gradual therapeutic regime;BRONCHOPULMONALE DYSPLASIE. RETROSPEKTIVE ANALYSE VERSCHIEDENER BEHANDUNGSFORMEN UND ENTWURF EINES THERAPEUTISCHEN STUFENPLANS

Klinische Padiatrie

Volumn 208, Issue 2, 1996, Pages 56-60

  Bauer, Jacqueline ^a   Beedgen, B ^a   Bohler Th ^a   Sontheimer, D ^a   Zilow, E P ^a   Linderkamp, O ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; DEXAMETHASONE;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FLUID INTAKE; HUMAN; HYPERGLYCEMIA; INHALATIONAL DRUG ADMINISTRATION; LUNG DYSPLASIA; NEWBORN; PREMATURITY;

EID: 0029933634     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043995     Document Type: Article

References (33)

1. Albersheim, S. G., A. J. Solimano, A. K. Sharma, J. A. Smyth, A. Rotschild, B. J. Wood, S. B. Sheps: Randomized, double-blind, controlled trial of long-term diuretic therapy in bronchopulmonary dysplasia. J. Pediatr. 115 (1989) 615-620
2. Alkalay, A. L., J. P. Pomerance, A. R. Puri, B. J. C. Lin, A. L. Vinstein, N. N. Neufeld, A. H. Klein: Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics 86 (1990) 204-210
3. Ariagno, R. L., T. E. Sweeney, W. H. Northway: Dexamethasone decreases lung water without affecting lung compliance in infant mice raised in 80% oxygen environment. Am. Rev. Respir. Dis. 133 (1986) A 108
4. Avery, G. B., A. B. Fletcher, M. Kaplan, D. S. Brudno: Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75 (1985) 106-111
5. Bancalari, E., G. E. Abdenour, R. Feller, J. Gannon: Bronchopulmonary dysplasia: Clinical presentation. J. Pediatr. 95 (1979) 819-823
6. Barnes, P., M. Jacobs, J. Roberts: Glucocorticoids preferentially increase fetal alveolar-adrenoreceptors: audioradiographic evidence. Pediatr. Res. 18 (1985) 1191-1194
7. Bell, E. F., D. Warburton, B. S. Stonestreet, W. Oh: Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N. Engl. J. Med. 302 (1980) 598-604
8. Cassoday, G.: A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N. Engl. J. Med. 320 (1989) 1511-1516
9. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial. Pediatrics 88 (1991) 421-427
10. Cummings, J. J., D. B. D'Eugenio, S. J. Gross: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N. Engl. J. Med. 320 (1989) 1505-1510
11. Davis, J. M., R. A. Sinkin, J. V. Aranda: Drug therapy for bronchopulmonary dysplasia. Pediatr. Pulmonol. 8 (1990) 117-125
12. De Lemos, R. A., D. W. Demos, J. H. Knelso, R. Kotas, M. E. Avery: Acceleration of appearance of surfactant in the fetal lamb by administration of corticosteroids. Am. Rev. Respir. Dis. 102 (1970) 459-461
13. Dunn, M. S., L. Magnani, M. Belaiche: Inhalated corticosteroids in severe bronchopulmonary dysplasia (BPD). Pediatr. Res. 25 (1989) 213 A
14. Ehrenkran, R. A., M. Mercurio: Bronchopulmonary dysplasia. In: J. C. Sinclair, M. B. Bracken (eds.): Effective Care of the Newborn Infant, Oxford University Press 1992, pp 399-422
15. Frank, L., P. Lewis, I. Sosenko: Dexamethasone stimulates fetal rat antioxidant enzyme activity in parallel with surfactant stimulation. Pediatr. Res. 18 (1984) 391 A
16. Groneck, P., V. Soditt, F. Bläker: Klinische Auswirkungen der Dexamethasontherapie bei Frühgeborenen mit hohem Risiko für eine bronchopulmonale Dysplasie. Monatschr. Kinderheilkd. 142 (1994) 279-284
17. Kao, L. C., D. J. Durand, B. L. Phillips, B. G. Nickerson: Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J. Pediatr. 11 (1987) 439-444
18. LaForce, W. R., D. S. Brudno: Controlled trial of beclomethasone dipropionate by nebulization in oxygen and ventilator-dependent infants. J. Pediatr. 122 (1993) 285-288
19. Linderkamp, O., W. Stolz, G. Bastert: Einfluß der Regionalisierung der Perinatalversorgung auf die Sterblichkeit und Langzeitfolgen kleiner Frühgeborener. Zentralbl. Gynäkol. 113 (1991) 1351-1360
20. Mammel, M. C., D. E. Johnson, T. P. Green, T. R. Thompson: Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1 (1983) 1356-1358
21. Merz, U., G. Kühl, O. Linderkamp: Dexamethason-Therapie bei bronchopulmonaler Dysplasie. Klin. Pädiatr. 201 (1989) 11-15
22. Noble-Jamieson, C. M., R. Regev, M. Silverman: Dexamethasone in neonatal chronic lung disease: Pulmonary effects and intracranial complications. Eur. J. Pediatr. 148 (1989) 365-367
23. Northway, W. H. Jr., R. C. Rosan, D. Y. Porter: Pulmonary disease following respiratory therapy of hyaline-membrane disease: bronchopulmonary displasia. N. Engl. J. Med. 276 (1967) 357-368
24. O'Brodovich, H. M., R. B. Mellins: Bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 132 (1985) 694-708
25. Pappagallo, M., O. Blondheim, V. Bhutani, S. Abbasi: Nebulized steroid trial in ventilator-dependent preterm infants. Pediatr. Res. 29 (1991) 327A
26. Ruiz, M. D., J. A. LeFever, D. O. Hakanson, D. A. Clark, M. G. Williams: Early development of infants of birth weight less than 1000 grams with reference to mechanical ventilation in newborn period. Pediatrics 68 (1981) 330-335
27. Rush, M. G., B. Engelhardt, R. A. Parker, T. A. Hazinski: Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia. J. Pediatr. 117 (1990) 112-118
28. Sahebjami, H., G. Jacob, D. Massaro: Influence of corticosteroid on recovery from oxygen toxicity. Am. Rev. Respr. Dis. 110 (1974) 566-571
29. Skubitz, K. M., P. R. Craddock, D. E. Hammerschmidt, J. T. August: Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes can cause disaggregation of granulocyte aggregates in vitro. J. Clin. Invest. 68 (1981) 13-20
30. Van Marter, L. J., A. Levinton, E. N. Allred, M. Pagano, K. C. K. Kuban: Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J. Pediatr. 116 (1990) 942-949
31. Von Stockhausen, H. B., M. Struve: Die Auswirkungen einer stark unterschiedlichen parenteralen Flüssigkeitszufuhr bei Früh- und Neugeborenen in den ersten drei Lebenstagen. Klin. Pädiat. 192 (1980) 539-546
32. Wilson, J. H.: Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid. Surg. Gynecol. Obstet. 134 (1972) 675-681
33. Yeh, T. F., J. A. Torre, A. Rastogni, M. A. Anyebuno, R. S. Pildes: Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind controlled study. J. Pediatr. 117 (1990) 273-282